Amphastar Pharmaceuticals AMPH Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's intangible amortization?
- Amphastar Pharmaceuticals (AMPH) reported intangible amortization of $6.27M in Q1 2026.
- How has Amphastar Pharmaceuticals's intangible amortization changed year-over-year?
- Amphastar Pharmaceuticals's intangible amortization increased by 0.5% year-over-year, from $6.24M to $6.27M.
- What is the long-term trend for Amphastar Pharmaceuticals's intangible amortization?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's intangible amortization has grown at a 119.9% compound annual growth rate (CAGR), from $1.07M to $25.05M.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.